Overview

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study to examine the feasibility and acceptability of simvastatin in adults with Recurrent Acute Pancreatitis (RAP) and Chronic Pancreatitis (CP).
Phase:
Early Phase 1
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborator:
United States Department of Defense
Treatments:
Simvastatin